The novel class of GLP-1 receptor agonist and GIP co-agonist medications, such as tirzepatide, semaglutide, and the relatively introduced retatrutide, provide promising progress in the treatment . https://peptidescience051158.kisa-blog.com/940373/tirzepatide-the-thorough-look